modified FOLFOX
Showing 1 - 25 of 4,952
Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)
Active, not recruiting
- Adenocarcinoma of the Stomach
- GastroEsophageal Cancer
- Nivolumab
- +3 more
-
Amberg, Germany
- +26 more
Jan 12, 2023
Colorectal Cancer Trial in Paris (FOLFOX regimen, fluorouracil, leucovorin calcium)
Active, not recruiting
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Paris, FranceGERCOR Groupe Cooperateur Multidisciplinaire en Oncologie
Jan 20, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Madrid (nab-paclitaxel, gemcitabine, m-FOLFOX)
Completed
- Metastatic Pancreatic Adenocarcinoma
- nab-paclitaxel
- +2 more
-
Madrid, SpainSpanish Cooperative for Digestive Tumour Therapy (TTD)
Aug 11, 2021
Hepatocellular Carcinoma Stage IIIa Trial in Hangzhou (Lenvatinib, mFOLFOX regimen, ROX regimen)
Enrolling by invitation
- Hepatocellular Carcinoma Stage IIIa
- Lenvatinib
- +2 more
-
Hangzhou, Zhejiang, ChinaThe Cancer Hospital of the University of Chinese Academy of Scie
Aug 12, 2021
Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)
Active, not recruiting
- Advanced Solid Tumors
- +3 more
- CAN04 (nadunolimab)
- +3 more
-
Saint-Herblain, Boulevard Jacques Monod, France
- +5 more
Oct 20, 2022
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric
Completed
- Unresectable Adenocarcinoma of the Esophagus
- +3 more
- FOLFOX
- +2 more
-
Los Angeles, California
- +1 more
Sep 3, 2021
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul (HERZUMA+mFOLFOX)
Recruiting
- HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
-
Seoul, Korea, Republic ofDivision of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Jan 19, 2021
Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)
Recruiting
- Colo-rectal Cancer
- Experimental: mXELOX plus cetuximab
- Active Comparator: FOLFOX plus cetuximab
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Rectal Cancer, Cancer of the Rectum, Colorectal Cancer Trial in United States (5-Fluorouracil, Bevacizumab, Radiation Therapy)
Metastatic Pancreatic Cancer Trial in Washington (ABT-888 and mFOLFOX-6)
Unknown status
- Metastatic Pancreatic Cancer
- ABT-888 and mFOLFOX-6
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020
Hepatocellular Cancer Trial in Boston (Leucovorin, Fluorouracil, Oxaliplatin)
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)
Not yet recruiting
- Neuropathy;Peripheral
- Placebo tablets
- Ketotifen Oral Tablet
-
Tanta, EgyptTanta university
Nov 23, 2022
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)
Recruiting
- Adenocarcinoma Esophagus
- Circulating tumor DNA(ctDNA) level measurement
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
May 23, 2022
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (5 µmol/kg), Placebo)
Terminated
- Colorectal Cancer
- Chemotherapy-induced Peripheral Neuropathy
- Calmangafodipir (5 µmol/kg)
- Placebo
-
Aalst, Belgium
- +64 more
Nov 19, 2021
Rectal Cancer Trial in Mecca (Chemotherapy)
Recruiting
- Rectal Cancer
-
Mecca, Makkah Western, Saudi ArabiaKing Abdullah Medical City, Holy Capital
Apr 5, 2022